STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,962,243 | -65.4% | 427,888 | -44.4% | 0.00% | -60.0% |
| Q3 2022 | $11,440,000 | -17.1% | 769,288 | -24.1% | 0.01% | -16.7% |
| Q2 2022 | $13,793,000 | +76527.8% | 1,013,071 | +196612.8% | 0.01% | – |
| Q1 2021 | $18,000 | -83.9% | 515 | -73.2% | 0.00% | – |
| Q4 2020 | $112,000 | +460.0% | 1,922 | +241.4% | 0.00% | – |
| Q3 2020 | $20,000 | -13.0% | 563 | -42.4% | 0.00% | – |
| Q2 2020 | $23,000 | -30.3% | 977 | -15.4% | 0.00% | – |
| Q4 2019 | $33,000 | – | 1,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |